Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01106274
Other study ID # MUMS-88191
Secondary ID
Status Completed
Phase N/A
First received April 16, 2010
Last updated April 16, 2010
Start date November 2008
Est. completion date September 2009

Study information

Verified date October 2008
Source Mashhad University of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority Iran: Ethics Committee
Study type Interventional

Clinical Trial Summary

Recently, riboflavin (0.1%) and ultraviolet-A (UVA) collagen cross-linking (C3R) has shown potential to improve the signs and symptoms of bullous keratopathy .The objective of this study is to demonstrate the effects of C3R to treat bullous keratopathy.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date September 2009
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- patients with bollous keratopathy

Exclusion Criteria:

- corneal scarring or contemporary eye disease affecting VA were excluded.

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Radiation:
ultraviolet-A
Corneal cross linking (C3R) with riboflavin and ultraviolet-A (UVA, 370 nm, 3mW/cm2) for 30 min

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mashhad University of Medical Sciences
See also
  Status Clinical Trial Phase
Completed NCT03248037 - Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation Phase 3
Enrolling by invitation NCT05956535 - Air Optix® Night and Day® Aqua Therapeutic Wear
Recruiting NCT02020044 - Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) N/A
Recruiting NCT03407755 - Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK) N/A
Completed NCT01448213 - Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK) Phase 2
Completed NCT03450954 - Long Term Results of Amniotic Membrane Transplant in Bullous Keratopathy Patients N/A
Completed NCT01926535 - Amniotic Membrane Graft In Syntomathic Bullous Keratopathy Phase 2
Completed NCT03763721 - The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation N/A
Completed NCT05891106 - AONDA Therapeutic Indication Study I
Active, not recruiting NCT04894110 - Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema Phase 1
Completed NCT00659308 - Amniotic Membrane and Anterior Stromal Puncture to the Treatment of Symptomatic Bullous Keratopathy N/A
Completed NCT01122043 - The SNEC DSAEK EndoGlide Clinical Trial N/A
Completed NCT00800111 - Study of Endothelial Keratoplasty Outcomes N/A
Recruiting NCT05636579 - Study to Assess Safety and Tolerability of Multiple Doses of EO2002 Phase 1
Recruiting NCT04319848 - Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty Phase 1
Recruiting NCT05436665 - The Belgian Endothelial Surgical Transplant of the Cornea N/A
Not yet recruiting NCT02736877 - Corneal Transplantation Guided by OCT RESCAN N/A